Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

TORC - Adicet Bio Inc

Previous close
2.28
2.280   100.000%

Share volume: 0
Last Updated: Tue 15 Sep 2020 10:00:01 PM CEST
Biotechnology: -0.86%

PREVIOUS CLOSE
CHG
CHG%
N/A
0.00
0.00%
This ticker is disabled and data are no longer maintained and up to date.
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
28%
Profitability 39%
Dept financing 2%
Liquidity 50%
Performance 18%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
0   0%
1 Month
0   0%
3 Months
0   0%
6 Months
0   0%
1 Year
0   0%
2 Year
0   0%
Key data
Stock price
$2.28
P/E Ratio 
N/A
DAY RANGE
$2.28 - $2.28
EPS 
-$1.81
52 WEEK RANGE
$0.86 - $10.50
52 WEEK CHANGE
-$78.16
MARKET CAP 
83.115 M
YIELD 
N/A
SHARES OUTSTANDING 
36.454 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
0.00
PUBLIC FLOAT 
$21,504,374
AVERAGE 10 VOLUME 
$356,687
AVERAGE 30 VOLUME 
$386,196
Company detail
CEO: Chen Schor
Region: US
Website: http://www.restorbio.com
Employees: 18
IPO year: -
Issue type: Common Stock
Market: NASDAQ
Industry: Biotechnology
Sector: Health Technology

resTORbio, Inc. is a clinical-stage biopharmaceutical company. The firm engages in the development and commercialization of medicines for aging-related diseases and conditions. It offers an immunotherapy under the TORC1 program. The company was founded by Chen Schor and Joan Mannick on July 5, 2016 and is headquartered in Boston, MA.

Recent news